Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

4D Molecular Therapeutics (FDMT) Return on Assets (2021 - 2025)

4D Molecular Therapeutics (FDMT) has disclosed Return on Assets for 5 consecutive years, with 0.28% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 1.0% to 0.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.28% through Dec 2025, down 1.0% year-over-year, with the annual reading at 0.25% for FY2025, 11.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.28% at 4D Molecular Therapeutics, up from 0.47% in the prior quarter.
  • The five-year high for Return on Assets was 0.18% in Q2 2024, with the low at 0.47% in Q3 2025.
  • Average Return on Assets over 5 years is 0.3%, with a median of 0.28% recorded in 2024.
  • The sharpest move saw Return on Assets rose 22bps in 2024, then dropped -23bps in 2025.
  • Over 5 years, Return on Assets stood at 0.24% in 2021, then crashed by -65bps to 0.4% in 2022, then increased by 28bps to 0.29% in 2023, then grew by 4bps to 0.28% in 2024, then fell by -2bps to 0.28% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.28%, 0.47%, and 0.4% for Q4 2025, Q3 2025, and Q2 2025 respectively.